Suboxone competition ramps up as Indivior and Mylan launch generics 25-Feb-2019 By Maggie Lynch Indivior launches generic of its own Suboxone film in the US, one day after court decision allows rivals to market generic versions.
Court grants restraining order as Suboxone litigations continue 29-Jan-2019 By Maggie Lynch Patent litigations over Suboxone generics continue as US District Court grants restraining order against Alvogen.
Teva settles litigation but keeps manufacturing on hold 07-Jan-2019 By Maggie Lynch Teva resolves generic patent infringement litigations that prohibited the manufacturing of two of its generic products.
Indivior succeeds in putting Suboxone generic on hold again 13-Dec-2018 By Maggie Lynch Indivior’s patent litigation with Dr. Reddy’s over Suboxone film continues after the company announced its preliminary injunction will stay in place.
Patent litigation over Dr. Reddy’s Suboxone generic continues 03-Dec-2018 By Maggie Lynch The US Court of Appeals for the Federal Circuit removed the injunction against Dr. Reddy’s, which prevented the company from selling its Suboxone generic.